Understanding vision loss in inherited retinal diseases
Official title: Photoreceptor Disease in Inherited Retinal Degenerations
Funded at University of Pennsylvania · NIH-11013365 · Data updated 2026-11-12
This study is looking at inherited eye diseases that cause vision loss, like retinitis pigmentosa and Stargardt disease, to find out which parts of the retina are most at risk over time, so we can create better ways to track and slow down vision loss for people affected by these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $577,403 |
| NIH project number | 5R01EY035675-02 |
| Project ID | NIH-11013365 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with inherited retinal diseases, particularly those with RHO or ABCA4 mutations.
✕Less likely to help
Patients with retinal diseases that are not genetically linked to the specific mutations being studied may not benefit from this research.
What this research studies
This research focuses on inherited retinal diseases (IRDs) that lead to progressive vision loss, specifically targeting conditions like autosomal dominant retinitis pigmentosa and Stargardt disease. By utilizing advanced genetic and genomic techniques, the project aims to identify specific retinal locations that are most vulnerable to deterioration over time. This individualized approach will help in developing better outcome measures for clinical trials, ultimately aiming to slow down vision loss in affected patients. The research employs artificial intelligence to enhance the prediction of disease progression, which could lead to more effective treatments.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for predicting and potentially slowing vision loss in patients with inherited retinal diseases.
How similar studies have gone: Previous research has shown promise in using genetic and AI-based approaches to understand and treat inherited retinal diseases, indicating a potential for success in this novel application.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Cideciyan, Artur V — University of Pennsylvania
- Study coordinator: Cideciyan, Artur V
Related research
Other NIH-funded projects on the same topics.
-
Comparing universal and guideline-directed genetic testing for young adults with cancer
This study is looking at whether a broader genetic test can help young adults with cancer find inherited risks that regular tests might miss, so they can get better treatment and care tailored just for them.
-
Better, searchable data for human pain biology
A data integration center will standardize, combine, and share molecular and cellular data from human pain research to help scientists understand how pain works and to accelerate discoveries.
-
Understanding how sweat glands form and work to help burn and skin injury patients
A study at the University of Pennsylvania looks at how sweat glands develop and function, with the goal of informing treatments for people who suffer traumatic skin injuries.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Understanding how a special airway cell helps protect and repair breathing passages
A researcher is studying a newly found airway cell called the hillock to see how it protects the airways and helps repair them after injury, with the aim of helping people with asthma, COPD, or bronchiectasis.
-
Defining TMJ cartilage progenitors and their regulatory niche for TMJ regeneration
Researchers are studying the cells that could help repair the jaw’s cartilage in TMJ osteoarthritis to lay the groundwork for regenerative therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.